Mr William Gietzmann

  • BA (Cantab) MA (Cantab) MBBS (KCL) FRCS Urol (Eng)
  • Consultant Urologist

Overview

William Gietzmann is a Consultant Urological Surgeon who subspecialises in open and minimally invasive renal cancer surgery. He also offers a comprehensive service of general urology and uro-oncology including benign prostate surgery. He began his medical training at the University of Cambridge gaining his intercalated degree in Medical Sciences and the History and Philosophy of Science in 2007. He completed his clinical studies at Guy’s King’s and St Thomas’ Medical School, London graduating in 2010.

He undertook his core surgical training in Sussex before completing his higher surgical training in the East of Scotland rotating through hospitals in Aberdeen, Edinburgh and Dundee. After undertaking a locum consultant post at the Aberdeen Royal Infirmary he moved to Oxford to take up his substantive post. He is actively involved in collaborative research having been appointed an honorary clinical lecturer at Aberdeen University. He has worked on several large systematic reviews including papers on behalf of the European Association of Urologists Guidelines Panel and lead authorship of a Cochrane Review.

Clinical interests

  • Kidney cancer
  • Bladder cancer
  • Kidney stones
  • Incontinence
  • Vasectomy
  • Benign prostatic enlargement
  • BPH
  • Urinary tract infections
  • Prostate cancer
  • Nephrectomy

Publications and affiliations

  • Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakkikhani P, Marconi L, Fernandez-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staelher M, Ljungberg B, Bex A. Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized RCC: results from a European multicenter database (RECUR). Scand j Urol. 2019 Feb;53(1):14-20. doi: 10.1080/21681805.2019.1588919.
  • Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakkikhani P, Marconi L, Fernandez-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staelher M, Ljungberg B, Bex A. Intensive Imaging based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database. Eur Urol. 2018; Oct 11. pii: S0302-2838(18)30748-6 doi: 10.1016/j.eururo.2018.10.007.
  • Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, Gietzmann W, Zakkikhani P, Marconi L, Fernandez-Pello S, Monagas S, Williams SP, Torbrand C, Powles T, Van Werkhoven E, Meijer R, Volpe A, Staelher M, Ljungberg B, Bex A. Long-term Outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. Eur Urol Focus. 2018 Mar;doi: 10.1016/j.euf.2018.02.010.
  • Van den Bergh RC, van Casteren NJ, van den Broeck T, Fordyce ER, Gietzmann W, Stewart, F, MacLennan S, Dabestani S, Bellmunt J, Bolla M, Briers E, Cornford P, Joniau S, Mason, MD, Matveev V, van der Poel HG, van der Kwast TH, Rouviere O, Wiegel T, Lam TB, Mottet N. Role of hormonal treatment in prostate cancer patients with nonmetastatic diseaserecurrence after local curative treatment: A systematic review. Eur Urol. 2016 May;69(5):802-20.
  • Ahmad S, Zakikhani P, Gietzmann W, Macdonald G, Royle J. Radiation therapy for urological cancer. Journal of Clinical Urology. 2016 Feb 26;9(3):142-150.

Professional memberships

  • British Association of Urological Surgeons
  • Royal College of Surgeons of England (Fellow)